You are here: All Products  > BioCity Completes Enrollment of ETA Agonist Trial in Patients with IgA Nephropathy

BioCity Completes Enrollment of ETA Agonist Trial in Patients with IgA Nephropathy

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products